These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Morphometric analysis of AgNORs in tubular and papillary parts of canine mammary gland tumors. Juntes P; Pogacnik M Anal Quant Cytol Histol; 2000 Jun; 22(3):185-92. PubMed ID: 10872033 [TBL] [Abstract][Full Text] [Related]
3. Correlation between the histopathological diagnosis by AgNOR count and AgNOR area in canine mammary tumors. Bundgaard-Andersen K; Flagstad A; Jensen AL; Hellmén E; Trerè D J Vet Intern Med; 2008; 22(5):1174-80. PubMed ID: 18624984 [TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors. Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219 [TBL] [Abstract][Full Text] [Related]
5. Computerized morphometry of mean nuclear diameter and nuclear roundness in canine mammary gland tumors on cytologic smears. Simeonov R; Simeonova G Vet Clin Pathol; 2006 Mar; 35(1):88-90. PubMed ID: 16511796 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of angiogenesis in canine mammary tumors. Graham JC; Myers RK J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723 [TBL] [Abstract][Full Text] [Related]
7. Computerized cytomorphometric analysis of nuclear area, nuclear perimeter and mean nuclear diameter in spontaneous canine mammary gland tumours. Simeonov R; Simeonova G Vet Res Commun; 2007 Jul; 31(5):553-8. PubMed ID: 17221362 [TBL] [Abstract][Full Text] [Related]
8. Discriminant analysis of image karyometric variables in benign and malignant melanocytic skin lesions. Mijovic Z; Mihailovic D Anal Quant Cytol Histol; 2002 Dec; 24(6):314-6. PubMed ID: 12508688 [TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog. Muto T; Wakui S; Takahashi H; Maekawa S; Masaoka T; Ushigome S; Furusato M Vet Pathol; 2000 May; 37(3):248-53. PubMed ID: 10810989 [TBL] [Abstract][Full Text] [Related]
10. Use of computerized interactive morphometry in the diagnosis of mammary adenoma and adenocarcinoma in dogs. Ciurea D; Wilkins RJ; Shalev M; Liu Z; Barba J; Gil J Am J Vet Res; 1992 Mar; 53(3):300-3. PubMed ID: 1595955 [TBL] [Abstract][Full Text] [Related]
11. Cellular proliferative and telomerase activity in canine mammary gland tumors. Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647 [TBL] [Abstract][Full Text] [Related]
12. Fractal dimension of canine mammary gland epithelial tumors on cytologic smears. Simeonov R; Simeonova G Vet Clin Pathol; 2006 Dec; 35(4):446-8. PubMed ID: 17123252 [TBL] [Abstract][Full Text] [Related]
13. Computer-assisted image analysis of intratumoral vessel density in mammary tumors from dogs. Griffey SM; Verstraete FJ; Kraegel SA; Lucroy MD; Madewell BR Am J Vet Res; 1998 Oct; 59(10):1238-42. PubMed ID: 9781454 [TBL] [Abstract][Full Text] [Related]
14. Comparison of B-mode and Doppler ultrasonographic findings with histologic features of benign and malignant mammary tumors in dogs. Nyman HT; Nielsen OL; McEvoy FJ; Lee MH; Martinussen T; Hellmén E; Kristensen AT Am J Vet Res; 2006 Jun; 67(6):985-91. PubMed ID: 16740091 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Sarli G; Preziosi R; Benazzi C; Castellani G; Marcato PS J Vet Diagn Invest; 2002 Jan; 14(1):25-34. PubMed ID: 12680640 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of cytologic criteria in ultrasound-guided fine-needle aspirates from subcentimeter canine mammary tumors. Pierini A; Millanta F; Zanforlin R; Vannozzi I; Marchetti V J Vet Diagn Invest; 2017 Nov; 29(6):869-873. PubMed ID: 28677423 [TBL] [Abstract][Full Text] [Related]
18. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study. Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393 [TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study. Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342 [TBL] [Abstract][Full Text] [Related]
20. Cytologic examination of fine-needle aspirates from mammary gland tumors in the dog: diagnostic accuracy with comparison to histopathology and association with postoperative outcome. Simon D; Schoenrock D; Nolte I; Baumgärtner W; Barron R; Mischke R Vet Clin Pathol; 2009 Dec; 38(4):521-8. PubMed ID: 19392751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]